Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2020 1
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
Eggermont AMM, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, Meshcheryakov A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, van Akkooi ACJ, Krepler C, Ibrahim N, Marreaud S, Kicinski M, Suciu S, Robert C; EORTC Melanoma Group. Eggermont AMM, et al. Lancet Oncol. 2021 May;22(5):643-654. doi: 10.1016/S1470-2045(21)00065-6. Epub 2021 Apr 12. Lancet Oncol. 2021. PMID: 33857412 Clinical Trial.
Melanoma - investigation and primary treatment.
Berentzen Å, Brevig T, Hermann R, Ryder T, Winge-Main AK. Berentzen Å, et al. Among authors: winge main ak. Tidsskr Nor Laegeforen. 2022 Oct 24;142(15). doi: 10.4045/tidsskr.22.0043. Print 2022 Oct 25. Tidsskr Nor Laegeforen. 2022. PMID: 36286571 Free article. English, Norwegian.
Correction: Melanoma - investigation and primary treatment.
Berentzen Å, Brevig T, Hermann R, Ryder T, Winge-Main AK. Berentzen Å, et al. Among authors: winge main ak. Tidsskr Nor Laegeforen. 2022 Dec 19;142(1). doi: 10.4045/tidsskr.22.0806. Print 2023 Jan 17. Tidsskr Nor Laegeforen. 2022. PMID: 36655962 Free article. English, Norwegian. No abstract available.